Cargando…

Myopia Control with a Novel Peripheral Gradient Soft Lens and Orthokeratology: A 2-Year Clinical Trial

Objective. To evaluate the degree of axial elongation with soft radial refractive gradient (SRRG) contact lenses, orthokeratology (OK), and single vision (SV) spectacle lenses (control) during a period of 1 year before treatment and 2 years after treatment. Methods. This was a prospective, longitudi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pauné, Jaime, Morales, Hari, Armengol, Jesús, Quevedo, Lluisa, Faria-Ribeiro, Miguel, González-Méijome, José M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641166/
https://www.ncbi.nlm.nih.gov/pubmed/26605331
http://dx.doi.org/10.1155/2015/507572
_version_ 1782400150722838528
author Pauné, Jaime
Morales, Hari
Armengol, Jesús
Quevedo, Lluisa
Faria-Ribeiro, Miguel
González-Méijome, José M.
author_facet Pauné, Jaime
Morales, Hari
Armengol, Jesús
Quevedo, Lluisa
Faria-Ribeiro, Miguel
González-Méijome, José M.
author_sort Pauné, Jaime
collection PubMed
description Objective. To evaluate the degree of axial elongation with soft radial refractive gradient (SRRG) contact lenses, orthokeratology (OK), and single vision (SV) spectacle lenses (control) during a period of 1 year before treatment and 2 years after treatment. Methods. This was a prospective, longitudinal, nonrandomized study. The study groups consisted of 30, 29, and 41 children, respectively. The axial length (AL) was measured during 2 years after recruitment and lens fitting. Results. The baseline refractive sphere was correlated significantly (Spearman's Rho (ρ) correlation = 0.542; P < 0.0001) with the amount of myopia progression before baseline. After 2 years, the mean myopia progression values for the SRRG, OK, and SV groups were −0.56 ± 0.51, −0.32 ± 0.53, and −0.98 ± 0.58 diopter, respectively. The results represent reductions in myopic progression of 43% and 67% for the SRRG and OK groups, respectively, compared to the SV group. The AL increased 27% and 38% less in the SRRG and OK groups, respectively compared with the SV group at the 2-year visit (P < 0.05). Axial elongation was not significantly different between SRRG and OK (P = 0.430). Conclusion. The SRRG lens significantly decreased AL elongation compared to the SV control group. The SRRG lens was similarly effective to OK in preventing myopia progression in myopic children and adolescent.
format Online
Article
Text
id pubmed-4641166
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-46411662015-11-24 Myopia Control with a Novel Peripheral Gradient Soft Lens and Orthokeratology: A 2-Year Clinical Trial Pauné, Jaime Morales, Hari Armengol, Jesús Quevedo, Lluisa Faria-Ribeiro, Miguel González-Méijome, José M. Biomed Res Int Clinical Study Objective. To evaluate the degree of axial elongation with soft radial refractive gradient (SRRG) contact lenses, orthokeratology (OK), and single vision (SV) spectacle lenses (control) during a period of 1 year before treatment and 2 years after treatment. Methods. This was a prospective, longitudinal, nonrandomized study. The study groups consisted of 30, 29, and 41 children, respectively. The axial length (AL) was measured during 2 years after recruitment and lens fitting. Results. The baseline refractive sphere was correlated significantly (Spearman's Rho (ρ) correlation = 0.542; P < 0.0001) with the amount of myopia progression before baseline. After 2 years, the mean myopia progression values for the SRRG, OK, and SV groups were −0.56 ± 0.51, −0.32 ± 0.53, and −0.98 ± 0.58 diopter, respectively. The results represent reductions in myopic progression of 43% and 67% for the SRRG and OK groups, respectively, compared to the SV group. The AL increased 27% and 38% less in the SRRG and OK groups, respectively compared with the SV group at the 2-year visit (P < 0.05). Axial elongation was not significantly different between SRRG and OK (P = 0.430). Conclusion. The SRRG lens significantly decreased AL elongation compared to the SV control group. The SRRG lens was similarly effective to OK in preventing myopia progression in myopic children and adolescent. Hindawi Publishing Corporation 2015 2015-10-28 /pmc/articles/PMC4641166/ /pubmed/26605331 http://dx.doi.org/10.1155/2015/507572 Text en Copyright © 2015 Jaime Pauné et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Pauné, Jaime
Morales, Hari
Armengol, Jesús
Quevedo, Lluisa
Faria-Ribeiro, Miguel
González-Méijome, José M.
Myopia Control with a Novel Peripheral Gradient Soft Lens and Orthokeratology: A 2-Year Clinical Trial
title Myopia Control with a Novel Peripheral Gradient Soft Lens and Orthokeratology: A 2-Year Clinical Trial
title_full Myopia Control with a Novel Peripheral Gradient Soft Lens and Orthokeratology: A 2-Year Clinical Trial
title_fullStr Myopia Control with a Novel Peripheral Gradient Soft Lens and Orthokeratology: A 2-Year Clinical Trial
title_full_unstemmed Myopia Control with a Novel Peripheral Gradient Soft Lens and Orthokeratology: A 2-Year Clinical Trial
title_short Myopia Control with a Novel Peripheral Gradient Soft Lens and Orthokeratology: A 2-Year Clinical Trial
title_sort myopia control with a novel peripheral gradient soft lens and orthokeratology: a 2-year clinical trial
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641166/
https://www.ncbi.nlm.nih.gov/pubmed/26605331
http://dx.doi.org/10.1155/2015/507572
work_keys_str_mv AT paunejaime myopiacontrolwithanovelperipheralgradientsoftlensandorthokeratologya2yearclinicaltrial
AT moraleshari myopiacontrolwithanovelperipheralgradientsoftlensandorthokeratologya2yearclinicaltrial
AT armengoljesus myopiacontrolwithanovelperipheralgradientsoftlensandorthokeratologya2yearclinicaltrial
AT quevedolluisa myopiacontrolwithanovelperipheralgradientsoftlensandorthokeratologya2yearclinicaltrial
AT fariaribeiromiguel myopiacontrolwithanovelperipheralgradientsoftlensandorthokeratologya2yearclinicaltrial
AT gonzalezmeijomejosem myopiacontrolwithanovelperipheralgradientsoftlensandorthokeratologya2yearclinicaltrial